2026 Seattle Lung Cancer Conference
Accreditation: 8.25 Nursing Contact Hours | 8.25 ABIM MOC II | 8.25 AMA PRA Category 1 Credit™ | 8.25 ACPE Pharmacy
Venue: Bell Harbor International Conference Center , 2211 Alaskan Way, Seattle, WA, 98121, United States
Official conference page for 2026 Seattle Lung Cancer Conference. https://binaytara.org/projects/conferences/2026-seattle-lung-cancer-conference
About 2026 Seattle Lung Cancer Conference


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Day 1: Friday, October 9th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
Session Chair: Siddhartha Devarakonda, MD
08:00 AM - 08:15 AM
Circulating tumor DNA in Screening & Diagnostics – Aadel Chaudhuri, MD, PhD
08:15 AM - 08:30 AM
Interventional Pulmonology – Krupa Kartan Solanki, MD
Session Chair: Siddhartha Devarakonda, MD
08:30 AM - 08:50 AM
Debate 1: Adjuvant vs. Neo-Adjuvant in NSCLC – Anjali Rohatgi, MD, PhD; Matthew Gumbleton, MD, PhD
08:50 AM - 09:10 AM
Debate 2: Consolidation in Metastatic NSCLC – Frank Weinberg, MD, PhD; Jing Zeng, MD
09:10 AM - 09:30 AM
Debate 3: Adjuvant/Neo-adjuvant TKIs: Pandora's Box or Ray of Hope? – Apar Kishor Ganti, MD; Rafael Santana-Davila, MD
09:30 AM - 09:50 AM
Debate 4: VEGF in NSCLC - Resurgence or Persistent Hype? – Janakiraman Subramanian, MD; Boone Goodgame, MD
09:50 AM - 10:15 AM
Q&A
Moderators:
Siddhartha Devarakonda, MD
10:30 AM - 11:00 AM
Discussion 1: PDL1 Negative and Low, STK11 Mutated
Moderators:
Kevin Levine, MD, PhD
Panelists:
Shrinjaya Thapa, MD; Ece Cali, MD, PhD; Lei Deng, MD
11:00 AM - 11:30 AM
Discussion 2: Locally Advanced & Early Stage NSCLC
Moderators:
Deepti Behl, MD
Panelists:
John Kang, MD, PhD; Prashanth Ashok Kumar, MD, FACP; Amith Ahuluwalia, MD; Smitha Menon, MD
12:30 PM - 01:15 PM
EGFR Evolution of the TKIs – Alexander Spira, MD, PhD, FACP
Catalysts:
Sylvia Lee, MD; Alexander Spira, MD, PhD, FACP; Aadel Chaudhuri, MD, PhD
Moderators:
Siddhartha Devarakonda, MD
Session Chair: Siddhartha Devarakonda, MD
02:30 PM - 02:40 PM
DLL3 – Konstantinos Leventakos, MD, PhD
02:40 PM - 02:50 PM
ADCs – Isabel Preeshagul, DO
02:50 PM - 03:00 PM
Novel Therapies – Brett Herzog, MD, PhD
03:00 PM - 03:15 PM
Panel and Q&A
Moderators:
Siddhartha Devarakonda, MD
Panelists:
Konstantinos Leventakos, MD, PhD; Isabel Preeshagul, DO; Brett Herzog, MD, PhD
Day 2: Saturday, October 10th, 2026
Session Chair: Lei Deng, MD
08:00 AM - 08:10 AM
ERBB2 Altered – Urs Michael Weber, MD
08:10 AM - 08:20 AM
ALK, ROS1, & RET – Cathleen Park, MD
08:20 AM - 08:30 AM
MTAP – Natalie Vokes, MD
08:30 AM - 08:40 AM
Trop 2 in Lung Cancer – Prashanth Ashok Kumar, MD, FACP
08:40 AM - 08:50 AM
EGFR Exon 20 and Uncommon – Arter Liao Zhaohui, MD
08:50 AM - 09:00 AM
MET Altered – Ece Cali, MD, PhD
09:00 AM - 09:10 AM
Q&A
Venue and map
Accreditations and continuing education
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education grant from Gilead Sciences.
